Lang Li
TitleCited byYear
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment
Y Jin, Z Desta, V Stearns, B Ward, H Ho, KH Lee, T Skaar, AM Storniolo, ...
Journal of the National Cancer Institute 97 (1), 30-39, 2005
10202005
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment
S Borges, Z Desta, L Li, TC Skaar, BA Ward, A Nguyen, Y Jin, ...
Clinical Pharmacology & Therapeutics 80 (1), 61-74, 2006
4932006
Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate
R Arora, MO Koch, JN Eble, TM Ulbright, L Li, L Cheng
Cancer: Interdisciplinary International Journal of the American Cancer …, 2004
2702004
Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant
M Fan, PS Yan, C Hartman-Frey, L Chen, H Paik, SL Oyer, JD Salisbury, ...
Cancer research 66 (24), 11954-11966, 2006
2352006
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer
NL Henry, F Azzouz, Z Desta, L Li, AT Nguyen, S Lemler, J Hayden, ...
Journal of Clinical Oncology 30 (9), 936, 2012
2262012
Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro
Z Desta, T Saussele, B Ward, J Blievernicht, L Li, K Klein, DA Flockhart, ...
Future Medicine Ltd 8 (6), 547-558, 2007
2022007
Nuclear factor-κB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate
C Sweeney, L Li, R Shanmugam, P Bhat-Nakshatri, V Jayaprakasan, ...
Clinical Cancer Research 10 (16), 5501-5507, 2004
1942004
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
NL Henry, JT Giles, D Ang, M Mohan, D Dadabhoy, J Robarge, J Hayden, ...
Breast cancer research and treatment 111 (2), 365-372, 2008
1842008
Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans
Z Wang, SD Hall, JF Maya, L Li, A Asghar, JC Gorski
British journal of clinical pharmacology 55 (1), 77-85, 2003
1782003
Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells
YC Lim, L Li, Z Desta, Q Zhao, JM Rae, DA Flockhart, TC Skaar
Journal of Pharmacology and Experimental Therapeutics 318 (2), 503-512, 2006
1672006
A community computational challenge to predict the activity of pairs of compounds
M Bansal, J Yang, C Karan, MP Menden, JC Costello, H Tang, G Xiao, ...
Nature biotechnology 32 (12), 1213, 2014
1452014
A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum‐resistant, epithelial ovarian cancer
F Fang, C Balch, J Schilder, T Breen, S Zhang, C Shen, L Li, ...
Cancer 116 (17), 4043-4053, 2010
1422010
Association of polymorphisms of angiogenesis genes with breast cancer
BP Schneider, M Radovich, GW Sledge, JD Robarge, L Li, AM Storniolo, ...
Breast cancer research and treatment 111 (1), 157-163, 2008
1422008
Prognostic DNA methylation biomarkers in ovarian cancer
SH Wei, C Balch, HH Paik, YS Kim, RL Baldwin, S Liyanarachchi, L Li, ...
Clinical Cancer Research 12 (9), 2788-2794, 2006
1352006
Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients
S Borges, Z Desta, Y Jin, A Faouzi, JD Robarge, S Philip, A Nguyen, ...
The Journal of Clinical Pharmacology 50 (4), 450-458, 2010
1062010
Variability of heart rate correction methods for the QT interval
M Desai, L Li, Z Desta, M Malik, D Flockhart
British journal of clinical pharmacology 55 (6), 511-517, 2003
1062003
Loss of 14-3-3σ in prostate cancer and its precursors
L Cheng, CX Pan, JT Zhang, S Zhang, MS Kinch, L Li, LA Baldridge, ...
Clinical cancer research 10 (9), 3064-3068, 2004
982004
Association between the CYP3A5 genotype and blood pressure
H Ho, A Pinto, SD Hall, DA Flockhart, L Li, TC Skaar, P Cadman, ...
Hypertension 45 (2), 294-298, 2005
952005
Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions
JD Duke, X Han, Z Wang, A Subhadarshini, SD Karnik, X Li, SD Hall, ...
PLoS computational biology 8 (8), 2012
882012
Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin
SK Quinney, X Zhang, A Lucksiri, JC Gorski, L Li, SD Hall
Drug metabolism and disposition 38 (2), 241-248, 2010
812010
The system can't perform the operation now. Try again later.
Articles 1–20